Low‐dose niacin supplementation modulates GPR109A, niacin index and ameliorates Parkinson's disease symptoms without side effects

Clinical Case Reports

Chandramohan Wakade¹  Raymond Chong¹  Eric Bradley¹ 

[1] Department of Physical Therapy, Georgia Regents University, Augusta, Georgia, USA

关键词: GPR109A;    inflammation;    niacin;    Parkinson's disease;   

DOI  :  10.1002/ccr3.232

来源: Wiley

【 摘 要 】

Key Clinical Message

A 65-year-old male, Parkinson's disease patient, was evaluated for GPR109A expression, niacin index, UPDRS scale, handwriting test, and quality of sleep with and without niacin treatment. The evaluation was repeated 3 months after niacin was stopped. Niacin modulated the abovementioned parameters and showed the overall improvement without side effects.

【 授权许可】

CC BY-NC   
© 2015 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.